Clinical Trials Browser

Phase 1 × sotigalimab × 90 days × Clear all

NCT02600949 2026-01-29

Personalized Peptide Vaccine in Treating Patients With Advanced Pancreatic Cancer or Colorectal Cancer

Phase 1 Active not recruiting

Gastrointestinal

Colorectal Neoplasms